Recommended TVUS Screening Thresholds May Miss Endometrial Cancer in Black Women
FRIDAY, July 23, 2021 -- Adherence to current clinical guidelines for the evaluation of postmenopausal bleeding may result in systematic underdiagnosis of endometrial cancer (EC) in Black women, according to a study published online July 15 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 23, 2021 Category: Pharmaceuticals Source Type: news

Baird Capital leads $12.8M Series B funding round for Houston health tech
Medical device company Saranas Inc. closed a $12.8 million Series B funding round, the firm announced July 19. The Series B round was led by Chicago-based Baird Capital, the venture capital and private equity arm of Milwaukee-based Robert W. Baird& Co. The round also saw participation from Austin, Texas-based S3 Ventures. Houston-based Saranas develops an FDA-approved medical device for early detection and monitoring of internal bleeding complications. Saranas' Early Bird device aims to improve… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 22, 2021 Category: Pharmaceuticals Authors: Chris Mathews Source Type: news

Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Benny Sorensen appointed Chief Executive Officer and Co-Founder Johan Henrik Faber appointed Chief Technology Officer Financing led by Novo Holdings, HealthCap and RA Capital Management Advancing pipeline of bispecific and monoclonal antibodies with ... Biopharmaceuticals, Venture Capital Hemab , thrombosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2021 Category: Pharmaceuticals Source Type: news

Shortages Reveal Low Priority of Women ’s Health in Nepal
Chiring Tamang holds the family’s new baby while his wife Priya looks on. She delivered the girl at home in their village in Nepal’s Sindhupalchowk district in February 2021. Credit: Marty Logan / IPSBy Marty LoganKathmandu, Nepal, Jul 21 2021 (IPS) One year after Nepal’s Ministry of Health (MoH) appealed to international organisations in the country to urgently supply a drug used to stop excessive bleeding after childbirth, a UN agency has delivered $1 million worth of contraceptives to prevent another shortage. The 1.6 million cycles of oral contraceptive pills and 776,000 units of injectable contracep...
Source: IPS Inter Press Service - Health - July 21, 2021 Category: International Medicine & Public Health Authors: Marty Logan Tags: Asia-Pacific COVID-19 Featured Gender Headlines Health Human Rights Humanitarian Emergencies Inequity TerraViva United Nations Women's Health contraceptives UNFPA United Nations Population Fund (UNFPA) Source Type: news

Lower Post-TAVR Mortality Seen on DOAC vs VKA When OAC Indicated Lower Post-TAVR Mortality Seen on DOAC vs VKA When OAC Indicated
Survival and bleeding risk were superior on the newer class of drugs after TAVR in a registry study of almost 9000 patients with an approved indication for oral anticoagulation.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 20, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Houston health tech firm Saranas raises $12.8M Series B
Houston-based medical device company Saranas Inc. closed a $12.8 million Series B funding round, the firm announced July 19. The Series B round was led by Chicago-based Baird Capital, the venture capital and private equity arm of Milwaukee-based Robert W. Baird& Co. The round also saw participation from Austin-based S3 Ventures. The Houston-based company develops an FDA-approved medical device for early detection and monitoring of internal bleeding complications. Saranas' Early Bird device aims… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 19, 2021 Category: Health Management Authors: Chris Mathews Source Type: news

Houston health tech firm Saranas raises $12.8M Series B
Houston-based medical device company Saranas Inc. closed a $12.8 million Series B funding round, the firm announced July 19. The Series B round was led by Chicago-based Baird Capital, the venture capital and private equity arm of Milwaukee-based Robert W. Baird& Co. The round also saw participation from Austin-based S3 Ventures. The Houston-based company develops an FDA-approved medical device for early detection and monitoring of internal bleeding complications. Saranas' Early Bird device aims… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 19, 2021 Category: Biotechnology Authors: Chris Mathews Source Type: news

Abelacimab Prevents VTE and Bleeding Risk in Knee Replacement Abelacimab Prevents VTE and Bleeding Risk in Knee Replacement
A monoclonal antibody that inhibits factor XI effectively reduces thromboembolism risk for knee-replacement patients, a new study suggests.Medscape Medical News (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - July 19, 2021 Category: Orthopaedics Tags: Orthopaedics News Source Type: news

When is Post-Operative Bleeding Most Likely to Occur after a Tonsillectomy?
Discussion Tonsillectomy is one of the most commonly performed surgical procedures in the US with pressure equalizing tubes and circumcisions also being among the top procedures. About 500,000 are performed yearly in the US in children under 15 years. Primary indications are recurrent throat infections (e.g. “
Source: PediatricEducation.org - July 19, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Life-saving snake venom
(University of Western Ontario) Western University bioengineer Kibret Mequanint and his international collaborators have found a novel use for snake venom: a body tissue 'super glue' that can stop life-threatening bleeding in seconds. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Dual Mechanisms of Protection Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., July 14, 2021 – Interim results from a Phase 1/2a sub-study published in the New England Journal of Medicine (NEJM) demonstrated that both humoral (antibody) and cellular (T-cell) immune responses generated by the Johnson & Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization, the length of time evaluated to date. Data showed that T-cell responses – including the important CD8+ T-cells that seek out and destroy infected cells – persisted over the eight-month timeframe examined. The Company announced topline preprint study results from...
Source: Johnson and Johnson - July 14, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Statement on COVID-19 Vaccine (7/12)
NEW BRUNSWICK, N.J., July 12, 2021 – The safety and well-being of the people who use our products is our number one priority. Rare cases of the neurological disorder, Guillain-Barré syndrome have been reported following vaccination with the Janssen COVID-19 vaccine. Most occurred within 42 days after vaccination. While the chance of having this occur is very low, Johnson & Johnson has updated its COVID-19 Vaccine Factsheet to include important information about these rare cases and on the signs and symptoms of Guillain-Barré syndrome. Updates with this new information will be implemented in other regions...
Source: Johnson and Johnson - July 12, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Blood on tissue after poo? The 11 potential causes of rectal bleeding
BLEEDING from your bum isn't always anything serious, but it could be life-threatening. Here are 13 potential causes of rectal bleeding. (Source: Daily Express - Health)
Source: Daily Express - Health - July 8, 2021 Category: Consumer Health News Source Type: news

Liberia: Bong County Maternal Mortality Crisis - Why Expectant Mothers Are Dying
[FrontPageAfrica] Gbarnla -- Meatta Browne had heard plenty of horror stories about women dying of post-partum bleeding while giving birth at home. But when she became pregnant with her first child, she discovered that a hospital birth was simply out of reach. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 8, 2021 Category: African Health Source Type: news

Impact of Age Examined for Ticagrelor Monotherapy After PCI
WEDNESDAY, July 7, 2021 -- For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2021 Category: Pharmaceuticals Source Type: news

Bleeding after hysterectomy: What can I expect?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - July 7, 2021 Category: Consumer Health News Source Type: news

DAPT vs. Aspirin in Patients With Stroke or TIA DAPT vs. Aspirin in Patients With Stroke or TIA
This study found that compared with aspirin alone, DAPT given within 24 hours of high-risk TIA or mild to moderate stroke reduces the risk of recurrent stroke, but comes with higher risk of bleeding.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Mayo Clinic Q and A: Bleeding moles and skin checks
DEAR MAYO CLINIC: I have a significant number of moles. While most do not bother me, I have at least one that bleeds from time to time. Should I see my doctor for a mole that bleeds? ANSWER: Moles are groups of pigment cells, and nearly everyone has them. Most moles are harmless, but it's possible for melanoma — a rare but serious skin cancer — to develop in or near a mole. Although it may not… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 2, 2021 Category: Databases & Libraries Source Type: news

Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response
NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the immune response lasted through at least eight months, the length of time evaluated to date. The two preprint study summaries have been submitted today to bioRxiv. “Today’s newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine ...
Source: Johnson and Johnson - July 1, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Lower BMI Cutoff Tied to Endometrial Cancer in Chinese Women
Lower obesity threshold of BMI ≥25 kg/m2 tied to increased risk of endometrial cancer in Asian women presenting with postmenopausal bleeding (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 30, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
New labeling approval for Abbott's XIENCE™ stent builds on a legacy of safety and allows for one-month (as short as 28 days) dual anti-platelet therapy (DAPT) for patients at high bleeding risk (HBR) The new XIENCE Skypoint™ stent received FDA approval ... Devices, Interventional, Cardiology, FDA Abbott, XIENCE, stent, dual anti-platelet therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 30, 2021 Category: Pharmaceuticals Source Type: news

Lower BMI Cutoff Tied to Endometrial Cancer in Chinese Women
WEDNESDAY, June 30, 2021 -- Body mass index (BMI) ≥25 kg/m2 is independently associated with increased risk of endometrial cancer among Chinese women presenting with postmenopausal bleeding, according to a study published online June 30 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 30, 2021 Category: Pharmaceuticals Source Type: news

Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
- New labeling approval for Abbott's XIENCE ™ stent builds on a legacy of safety and allows for one-month (as short as 28 days) dual anti-platelet therapy (DAPT) for patients at high bleeding risk (HBR) (Source: Abbott.com)
Source: Abbott.com - June 30, 2021 Category: Pharmaceuticals Source Type: news

Postmenopausal bleeding may be a sign of endometrial cancer in obese Asian women
(The North American Menopause Society (NAMS)) The link between obesity and the risk of endometrial cancer has been well documented. A new study, however, shows that an even lower body mass index (BMI) than previously thought can signal an increased risk in Asian women with postmenopausal bleeding. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2021 Category: International Medicine & Public Health Source Type: news

Tranexamic Acid in Hip and Pelvic Fracture Surgeries Tranexamic Acid in Hip and Pelvic Fracture Surgeries
Tranexamic acid is routinely used to control bleeding in a wide range of conditions. Is it safe to use in hip and pelvic fracture surgery?Journal of the American Academy of Orthopaedic Surgeons (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2021 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Kenya: Empowering Kenyan Women and Girls With Disabilities in Managing Menstrual Health
[UNFPA] Anne Wanjiru found out she had gotten her first period when a boarding school classmate told her she had stained her dress. No one had ever explained menstruation to her, so the then-14-year-old, who had a congenital mobility disability and hearing impairment, did not understand why she felt discomfort and pain or why she was bleeding. "I didn't even know how to wear a sanitary pad," she said." A teacher explained periods were normal, gave her underwear and pads, showed her to use them and checked on her e (Source: AllAfrica News: Pregnancy and Childbirth)
Source: AllAfrica News: Pregnancy and Childbirth - June 24, 2021 Category: OBGYN Source Type: news

Empowering Kenyan women and girls with disabilities in managing menstrual health
NAIROBI, Kenya –Anne Wanjiru found out she had gotten her first period when a boarding school classmate told her she had stained her dress. No one had ever explained menstruation to her, so the then-14-year-old, who had a congenital mobility disability and hearing impairment, did not understand why she felt discomfort and pain or why she was bleeding. “I didn’t even know how to wear a sanitary pad,” she said.” A teacher explained periods were normal, gave her underwear and pads, showed her to use them and checked on her every day.   (Source: UNFPA News)
Source: UNFPA News - June 24, 2021 Category: International Medicine & Public Health Authors: UNFPA - United Nations Population Fund Source Type: news

No Benefit to Therapeutic Oral Anticoagulation in COVID-19 Hospitalizations No Benefit to Therapeutic Oral Anticoagulation in COVID-19 Hospitalizations
In patients hospitalized with COVID-19 and elevated D-dimer concentrations, therapeutic dosing of oral anticoagulants did not improve outcomes compared with prophylactic anticoagulation, and it also increased bleeding, a large trial found.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 23, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of Enseal X1 Curved Jaw Tissue Sealer
CINCINNATI, OH – June 21, 2021 -- Ethicon*, part of the Johnson & Johnson Medical Devices Companies,** today announced the launch of the ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency[1] and provided stronger sealing[2] and better access to more tissue than LigaSure™ Maryland.[3] The device is indicated for colorectal, gynecological, bariatric surgery and thoracic procedures. The ENSEAL X1 Curved Jaw is the first of several new advanced laparoscopic bipolar devices the company plans to launch in the coming months as it expands its extensive ener...
Source: Johnson and Johnson - June 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Covid vaccine: MHRA is ‘closely monitoring’ reports of ‘unexpected vaginal bleeding'
CORONAVIRUS vaccines - such as Moderna, AstraZeneca and Pfizer - are still being investigated by the Medicines and Healthcare Regulatory Agency while being put into millions of people's upper arms. (Source: Daily Express - Health)
Source: Daily Express - Health - June 20, 2021 Category: Consumer Health News Source Type: news

Does radiology AI need more clinical validation?
An artificial intelligence (AI) algorithm for detecting cervical spine fracture...Read more on AuntMinnie.comRelated Reading: How can radiologists benefit from AI in 2021? How well can AI software spot intracranial bleeding on head CT? Keep aware of head and neck injuries in winter sports Rads offer key support to domestic violence victims Will Medicare reimbursement propel radiology AI market? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 18, 2021 Category: Radiology Source Type: news

Apocalypse Now? Christian Fundamentalists and COVID-19
By Jan LundiusSTOCKHOLM / ROME, Jun 17 2021 (IPS)   Getting hard to breathe hard to believe in anything at all, but fear. Peter Gabriel, Mother of ViolenceLike most male Swedes of my age I had to enter obligatory military service for almost a year. In my barrack was a “born-again-Christian” who when he became angry shouted “Now you mock me, but when the Last Judgement has come I will sit in heaven and smile down at you while you burn in Hell!” Since then I have wondered about the last book of the Bible, the Book of Revelation. It was written by a frustrated Christian man who by the end of 100 C...
Source: IPS Inter Press Service - Health - June 17, 2021 Category: International Medicine & Public Health Authors: Jan Lundius Tags: Crime & Justice Featured Global Headlines Health Human Rights Humanitarian Emergencies Religion TerraViva United Nations Source Type: news

LIVFRESH Becomes the World ’s First European Union CE Mark Certified Toothpaste for Prevention & Treatment of Periodontitis & Gingivitis as an Adjunct to Professional Care
~ As Mounting Evidence Connects Gum Disease to Covid Complications, Silicon Valley Based LIVFRESH Dental Gel is approved in the European Union as the First Over the Counter Toothpaste for Consumers Suffering from Periodontitis or Gingivitis. These Oral Diseases Affect up to 90% of All Adults.Los Gatos, CA —June 2, 2021—As the world continues to fight COVID, and since serious gum disease (periodontitis) has been implicated as a complicating factor, good oral health is more important than ever.   Livionex Inc., the company behind LivFresh Dental Gel, today, announced its therapeutic non-abrasive and det...
Source: Dental Technology Blog - June 17, 2021 Category: Dentistry Source Type: news

Reversal Agents Curb DOAC-related Bleeding but Deaths Still High Reversal Agents Curb DOAC-related Bleeding but Deaths Still High
The meta-analysis of more than 4000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 14, 2021 Category: Intensive Care Tags: Cardiology News Source Type: news

A rare suicide case involving fatal bleeding from varicose veins - Handlos P, Handlosov á K, Klabal O, Uvíra M.
This case report deals with a sharp force suicide case, which may challenge the experience of many forensic pathologists as well as the studies published to date. An overview of the published cases shows that sharp force suicides account only for 1.6%-3% o... (Source: SafetyLit)
Source: SafetyLit - June 14, 2021 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Fatty liver disease: Early warning risks could include unusual bleeding - like nosebleeds
FATTY liver disease: For cirrhosis to develop, long-term, continuous damage to the liver needs to occur. This continuous damage can lead to a variety of major health conditions which could be fatal. An early sign of the disease includes epistaxis. (Source: Daily Express - Health)
Source: Daily Express - Health - June 14, 2021 Category: Consumer Health News Source Type: news

New Phase 3 Study Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVICA® plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study demonstrated superior progression-free survival (PFS) of a once-daily, all-oral, fixed-duration regimen of I+V versus Clb+O as first-line treatment of CLL; the study also showed improved duratio...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AstraZeneca vaccine side effects: Idiopathic thrombocytopenic may cause internal bleeding
ASTRAZENECA vaccine side effects: A blood disorder which causes bruising, bleeding gums and even internal bleeding has recently been reported. (Source: Daily Express - Health)
Source: Daily Express - Health - June 10, 2021 Category: Consumer Health News Source Type: news

AstraZeneca jab linked to rare bleeding disorder that can cause purple-dotted rash
ASTRAZENECA may lead to immune thrombocytopenic purpura - a rare blood disorder - in around one in 100,000 people. This finding surfaced from ongoing analysis in the short and long-term side effects of the vaccine. (Source: Daily Express - Health)
Source: Daily Express - Health - June 10, 2021 Category: Consumer Health News Source Type: news

Covishield vaccine carries slightly higher risk of bleeding disorders: Study
Reports of rare clotting and bleeding disorders in younger adults, some fatal, led a number of countries to limit the vaccine ’s use to older people, and a few to drop it altogether. (Source: The Economic Times)
Source: The Economic Times - June 10, 2021 Category: Consumer Health News Source Type: news

AstraZeneca Shots Carry Slightly Higher Risk of Bleeding Problem, New Study Says
But the research, involving 2.53 million adults in Scotland, found that the vaccine ’s benefits outweighed the small risks. (Source: NYT Health)
Source: NYT Health - June 9, 2021 Category: Consumer Health News Authors: Denise Grady Tags: Vaccination and Immunization Coronavirus Risks and Safety Concerns Coronavirus (2019-nCoV) Blood Blood Clots Research Content Type: Service AstraZeneca PLC Nature Medicine (Journal) Oxford University Scotland your-feed-healthcare P Source Type: news

AstraZeneca's Covid vaccine is linked to another bleeding disorder that can cause purple-dotted rash
Researchers spotted the link after analysing data from 5.4million people in Scotland between December 8 and April 14. (Source: the Mail online | Health)
Source: the Mail online | Health - June 9, 2021 Category: Consumer Health News Source Type: news

AstraZeneca vaccine linked to slightly higher risk of blood disorder
Analysis in Scotland finds small increase in risk of treatable condition called idiopathic thrombocytopenic purpuraCoronavirus – latest updatesSee all our coronavirus coverageData from Scotland ’s Covid vaccination programme has revealed a possible small increase in the risk of a treatable and often mild bleeding disorder after the first dose of the Oxford/AstraZeneca vaccine.Doctors examined the medical records of 5.4 million people in Scotland for instances of blood clots, unusual bleeding, and a condition called idiopathic thrombocytopenic purpura (ITP), where a reduction in blood platelets can lead to easy ...
Source: Guardian Unlimited Science - June 9, 2021 Category: Science Authors: Ian Sample Science editor Tags: Coronavirus Science Vaccines and immunisation UK news Scotland Health Source Type: news

What do Covid-19 vaccines, canola oil and margarine have in common? They all clog your blood
(Natural News) When it comes to blood clots and coagulation, clotting factors are proteins found in the blood that work together to make a blood clot, to keep you from bleeding out. But what happens to humans when their blood clots unnaturally, where there is no cut, inside their blood vessels that deliver oxygen and... (Source: NaturalNews.com)
Source: NaturalNews.com - June 9, 2021 Category: Consumer Health News Source Type: news

Haemorrhage control beyond Advanced Trauma Life Support (ATLS) protocol in life threatening maxillofacial trauma - experience from a level Ⅰ trauma centre - Dar PMUD, Gupta P, Kaul RP, Kumar A, Gamangatti S, Kumar S, Gupta A, Singhal M, Sagar S.
Maxillofacial injuries are usually not life-threatening and do not get priority over other associated injuries. However, some maxillofacial injuries with active oral or nasal bleeding need immediate management due to threatened airway and blood loss. In th... (Source: SafetyLit)
Source: SafetyLit - June 9, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Hormonal contraceptive use in Ghana: the role of method attributes and side effects in method choice and continuation
Conclusions Ghanaian women value hormonal methods for their effectiveness against pregnancy. However, concerns about side effects (particularly bleeding changes), future fertility impairment, and long-term health issues led some women to discontinue hormonal methods. Counseling on these issues was reportedly inadequate. (Source: The Guttmacher Institute)
Source: The Guttmacher Institute - June 8, 2021 Category: International Medicine & Public Health Authors: Guttmacher Source Type: news

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19, University of Oxford
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19. Patients with COVID-19 are at increased risk of blood clots forming in their blood vessels, particularly in the lungs. Between November 2020 and March 2021, the RECOVERY trial included nearly 15,000 patients hospitalised with COVID-19 in an assessment of the effects of aspirin, which is widely used to reduce blood clotting in other diseases. A total of 7351 patients were randomised to aspirin 150 mg once daily and compared with 7541 patients randomised to usual care alon...
Source: Current Awareness Service for Health (CASH) - June 8, 2021 Category: Consumer Health News Source Type: news

Fibroid Pain, Bleeding Is Driving Thousands of Women to the ER
TUESDAY, June 8, 2021 -- Far too many women are showing up in U.S. emergency rooms due to fibroids, according to a new study spanning 12 years. Fibroids are common noncancerous growths in the uterus. They don't always cause symptoms, but those that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 8, 2021 Category: General Medicine Source Type: news